ImmuneBridge

Website

Developer of allogeneic cellular immunotherapies designed for advancing cancer treatment. The company's immunotherapies utilize proprietary expansion technology to amplify cord blood-derived immune st...

Healthcare
San Francisco, CA, United States
Founded 2018
19 employees
Website
Valuation
$11M
Market implied
Share Price
N/A
Total Raised
$17.6M
Last Round
N/A
Investors
+12 other investors
View all 12 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock ImmuneBridge's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required